Baltimore, Maryland
Phase 1 colorectal cancer trials in Baltimore, MD
14 Phase 1 colorectal cancer studies are recruiting participants at sites in Baltimore as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Baltimore at a glance
- 14 studies are recruiting at a site in Baltimore.
- By phase: Phase 1 (7), Phase 1/2 (7).
- By sponsor: industry (12), government (1), university, hospital or other (1).
- Most recent update to one of these records: November 10, 2026.
Studies recruiting in Baltimore
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Johns Hopkins University
- Registry record
- NCT07020221 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT05919264 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #14
- Registry record
- NCT05176483 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
- Registry record
- NCT06445062 · updated
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Johns Hopkins
- Registry record
- NCT07349537 · updated
Safety of HRX215 in Patients After Minor and Major Liver Resection
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- HepaRegeniX GmbH
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT06638502 · updated
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Johns Hopkins University/Sidney Kimmel Cancer Center · University of Maryland/Greenebaum Cancer Center
- Registry record
- NCT07147231 · updated
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT06411691 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins
- Registry record
- NCT06131840 · updated
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
- Registry record
- NCT06179160 · updated
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Johns Hopkins University
- Registry record
- NCT06040541 · updated
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT07223047 · updated
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Johns Hopkins University
- Registry record
- NCT05379985 · updated
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Clasp Therapeutics, Inc.
- Study site
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT06778863 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.
Ask about studies near Baltimore
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections